48232 Federal Register / Vol. 82, No. 199 / Tuesday, October 17, 2017 / Notices 

Acquisition Policy Division, GSA, 202– 

969–7207 or email zenaida.delgado@

gsa.gov. 

SUPPLEMENTARY INFORMATION: 

A. Purpose 

The Affidavit of Individual Surety SF 

28 is used by all executive agencies, 

including the Department of Defense, to 

obtain information from individuals 

wishing to serve as sureties to 

Government bonds. To qualify as a 

surety on a Government bond, the 

individual must show a net worth not 

less than the penal amount of the bond 

on the SF 28. It is an elective decision 

on the part of the maker to use 

individual sureties instead of other 

available sources of surety or sureties 

for Government bonds. We are not 

aware if other formats exist for the 

collection of this information. 

The information on SF 28 is used to 

assist the contracting officer in 

determining the acceptability of 

individuals proposed as sureties. 

B. Annual Reporting Burden 

Respondents: 500. 

Responses per Respondent: 1. 

Total Responses: 500. 

Hours per Response: 0.3. 

Total Burden Hours: 150. 

C. Public Comments 

Public comments are particularly 

invited on: Whether this collection of 

information is necessary for the proper 

performance of functions of the FAR, 

and whether it will have practical 

utility; whether our estimate of the 

public burden of this collection of 

information is accurate, and based on 

valid assumptions and methodology; 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and ways in which we can 

minimize the burden of the collection of 

information on those who are to 

respond, through the use of appropriate 

technological collection techniques or 

other forms of information technology. 

Obtaining Copies of Proposals: 

Requesters may obtain a copy of the 

information collection documents from 

the General Services Administration, 

Regulatory Secretariat Division (MVCB), 

1800 F Street NW., Washington, DC 

20405, telephone 202–501–4755. Please 

cite OMB Control No. 9000–0001, SF 28, 

Affidavit of Individual Surety, in all 

correspondence. 

Dated: October 11, 2017. 

Lorin S. Curit, 

Director, Federal Acquisition Policy Division, 

Office of Government-wide Acquisition 

Policy, Office of Acquisition Policy, Office 

of Government-wide Policy. 

[FR Doc. 2017–22450 Filed 10–16–17; 8:45 am] 

BILLING CODE 6820–EP–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Request for Nominations of Potential 

Reviewers To Serve on the Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC) is seeking 

nominations for possible membership 

on the Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP) in the National 

Institute for Occupational Safety and 

Health (NIOSH), World Trade Center 

Health Program (WTCHP). The Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel 

provides advice and guidance to the 

Secretary, Department of Health and 

Human Services (HHS); the Director, 

Centers for Disease Control and 

Prevention (CDC), and the 

Administrator, Agency for Toxic 

Substances and Disease Registry 

(ATSDR) regarding the concept review, 

scientific and technical merit of grant 

and cooperative agreement assistance 

applications, and contract proposals 

relating to the causes, prevention, and 

control of diseases, disabilities, injuries, 

and impairments of public health 

significance; exposure to hazardous 

substances in the environment; health 

promotion and education; and other 

related activities that promote health 

and well-being. Members and Chairs 

shall be selected by the Secretary, HHS, 

or other official to whom the authority 

has been delegated, on an ‘‘as needed’’ 

basis in response to specific 

applications being reviewed with 

expertise to provide advice. Members 

will be selected from authorities in the 

various fields of prevention and control 

of diseases, disabilities, and injuries. 

Members of other chartered HHS 

advisory committees may serve on the 

panel if their expertise is required. 

Consideration is given to professional 

training and background, points of view 

represented, and upcoming applications 

to be reviewed by the committee. 

DATES: Nominations for membership on 

the WTCHP SEPs must be received no 

later than December 15, 2017. Packages 

received after this time will not be 

considered for the current membership 

cycle; but will be kept on file for future 

cycles. The membership cycles are 

listed under the Advisory Council 

Review on the Funding Opportunity 

Announcement, which is available at: 

https://grants.nih.gov/grants/guide/pafiles/PAR-16-098.html. 

ADDRESSES: All nominations should be 

mailed to Centers for Disease Control 

and Prevention, 1600 Clifton Road NE., 

Mailstop E–74, Atlanta, Georgia 30329, 

emailed to wtcscience@cdc.gov, or faxed 

to (404) 471–2616. 

FOR FURTHER INFORMATION CONTACT: Mia 

Wallace, Management Analyst, CDC/ 

NIOSH/WTCHP, 1600 Clifton Road NE., 

Mailstop E–74, Atlanta, Georgia 30329, 

Telephone: (404) 498–2253; Email: 

mwallace@cdc.gov. 

SUPPLEMENTARY INFORMATION: The U.S. 

Department of Health and Human 

Services policy stipulates that 

committee membership be balanced in 

terms of points of view represented and 

the committee’s function. Appointments 

shall be made without discrimination 

on the basis of age, race, ethnicity, 

gender, sexual orientation, gender 

identity, HIV status, disability, and 

cultural, religious, or socioeconomic 

status. Nominees must be U.S. citizens 

appointed to serve on a CDC SEP and 

can be full-time employees of the U.S. 

Government. Current participation on 

CDC federal workgroups or prior 

experience serving on another federal 

advisory committee does not disqualify 

a reviewer. However, HHS policy is to 

avoid excessive individual service on 

advisory committees and multiple 

committee memberships. Reviewers 

appointed to the SEP, CDC are not 

considered Special Government 

Employees, and will not be required to 

file financial disclosure reports. 

Nominees interested in serving as a 

member on a WTCHP Peer Review 

Panel should submit the following 

items: 

• Current curriculum vitae, including 

complete contact information (name, 

affiliation, mailing address, telephone 

number, and email address); 

• A statement summarizing the 

nominee’s Areas of Expertise (include 

unique experiences, skills and 

knowledge the individual will bring to 

the WTCHP), Ethnic/Racial Minority 

Status, and Citizenship; and 

• A statement confirming that the 

nominee is not a registered federal 

lobbyist. 


sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 82, No. 199 / Tuesday, October 17, 2017 / Notices 48233 

Background: The WTCHP is 

administered by NIOSH. The James 

Zadroga 9/11 Health and Compensation 

Act of 2010, Public Law 111–347 

(hereafter referred to as ‘‘the Zadroga 

Act’’) was signed by President Obama 

on January 2, 2011, and was reauthorized on December 18, 2015. The 

Zadroga Act continues monitoring and 

treatment activities and requires the 

establishment (under Subtitle C) of a 

research program on health conditions 

resulting from the September 11, 2001, 

terrorist attacks. For additional 

information on the program please refer 

to: http://www.cdc.gov/wtc. 

The Zadroga Act lists the following 

broad research areas: 

• Physical and mental health 

conditions that may be related to the 

September 11, 2001, terrorist attacks; 

• Diagnosing WTC-related health 

conditions for which there has been 

diagnostic uncertainty; and 

• Treating WTC-related health 

conditions for which there has been 

treatment uncertainty. 

Research mentioned in the Zadroga 

Act includes epidemiologic and other 

research studies on WTC-related health 

conditions or emerging conditions 

among (1) enrolled WTC responders and 

certified-eligible WTC survivors under 

treatment; (2) sampled populations 

outside the NYC disaster area, in 

Manhattan (as far north as 14th Street) 

and in Brooklyn; and (3) control 

populations, to identify potential for 

long-term adverse health effects in less 

exposed populations. 

Major areas of interest include, but are 

not limited to, the following: 

Linking 9/11 exposure to health 

conditions: 

• Cancers, multisystem or 

autoimmune, cardiovascular and 

neurologic disease (including age at 

diagnosis); 

• Characterizing patterns of illness 

(age, gender, comorbidities, etc.); and 

• Characterizing alterations in health 

and development for those exposed to 

9/11 as children. 

Characterizing established WTCrelated diseases and comorbidities: 

• Identifying phenotypes, biomarkers, 

epigenetics; and 

• Care models that address complex 

co-morbidities and other modifiable 

factors. 

• Health services research and valuebased care that addresses disasterrelated injury and illness for chronic 

disease. 

(Note: Health services research 

examines how people get access to 

health care, how much care costs, and 

what happens to patients as a result of 

this care. The main goals of health 

services research are to identify the 

most effective ways to organize, 

manage, finance, and deliver high 

quality care; reduce medical errors; and 

improve patient safety (Agency for 

Healthcare Research and Quality, 2002). 

Characterizing the work-ability and 

occupational outcomes for those 

impacted by 9/11. 

Lessons learned in recovery: 

• Identifying and operationalizing 

key elements of psychological resilience 

for disaster responders; and 

• Establishing comparison groups for 

disaster-related research for key health 

indicators for first responders. 

(Note: Concepts of psychological 

resilience vary across disciplines with 

investigations addressing various 

outcomes ranging from reported levels 

of stress, burnout, compassion fatigue, 

and general indicators of well-being. 

Also proposed are interpersonal, 

intrapersonal and environmental factors 

that suggest a more stable and enduring 

personality trait impacting selfregulation.) 

Relevant diseases or conditions 

include, but are not limited to, the 

following: 

• Respiratory diseases 

• Cancer (including detection/diagnosis 

of pre-malignant changes) 

• Cardiovascular Disease 

• Psychological resilience and wellbeing 

• Persistent psychiatric conditions such 

as posttraumatic stress, anxiety and 

depressive disorders 

• Cognitive changes 

• Aging—the impacts of aging on those 

impacted by 9/11 illness and injury 

• Neurological Diseases 

• Aerodigestive health 

• Multisystem or auto-immune diseases 

• Gastro-esophageal disorders 

• Gastrointestinal health 

• Chronic musculoskeletal conditions 

resulting from acute traumatic injury 

and overuse disorders 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2017–22436 Filed 10–16–17; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; 

Comment Request 

Title: Form ACF–196R, ‘‘TANF 

Quarterly Financial Report’’ 

OMB No.: 0970–0446 

Description: This information 

collection is authorized under Section 

411(a)(3) of the Social Security Act. This 

request is for continued approval of 

Form ACF–196R for quarterly financial 

reporting under the Temporary 

Assistance for Needy Families (TANF) 

program. States participating in the 

TANF program are required by statute to 

report financial data on a quarterly 

basis. The forms meet the legal standard 

and provide essential data on the use of 

federal TANF funds. Failure to collect 

the data would seriously compromise 

ACF’s ability to monitor program 

expenditures, estimate funding needs, 

and to prepare budget submissions and 

annual reports required by Congress. 

Financial reporting under the TANF 

program is governed by 45 CFR part 

265. 

This form was first developed in 2014 

to replace Form ACF–196. No changes 

are being proposed with this request for 

OMB review. No comments were 

received in response to the publication 

of the initial Federal Register Notice on 

May 30, 2017, 82 FR 24714. 

Respondents: State agencies 

administering the TANF program (50 

States plus the District of Columbia) 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden hours 

per response 

Total 

burden hours 

ACF–196R ....................................................................................................... 51 4 14 2,856 


sradovich on DSK3GMQ082PROD with NOTICES